RU2006112576A - Получение производных 3-азабицикло [3.1.0] гексана - Google Patents

Получение производных 3-азабицикло [3.1.0] гексана Download PDF

Info

Publication number
RU2006112576A
RU2006112576A RU2006112576/04A RU2006112576A RU2006112576A RU 2006112576 A RU2006112576 A RU 2006112576A RU 2006112576/04 A RU2006112576/04 A RU 2006112576/04A RU 2006112576 A RU2006112576 A RU 2006112576A RU 2006112576 A RU2006112576 A RU 2006112576A
Authority
RU
Russia
Prior art keywords
alkyl
hydroxy
azabicyclo
exo
hex
Prior art date
Application number
RU2006112576/04A
Other languages
English (en)
Russian (ru)
Inventor
Джотам Уодсворт КОЭ (US)
Джотам Уодсворт КОЭ
Стэнтон Фурст МАКХАРДИ (US)
Стэнтон Фурст МАКХАРДИ
Джон Энтони РЭГАН (US)
Джон Энтони РЭГАН
Дерек Лоуренс ТИКНЕР (US)
Дерек Лоуренс ТИКНЕР
Брайан Клемент ВАНДЕРПЛАС (US)
Брайан Клемент ВАНДЕРПЛАС
Original Assignee
Пфайзер Продактс Инк. (Us)
Пфайзер Продактс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Продактс Инк. (Us), Пфайзер Продактс Инк. filed Critical Пфайзер Продактс Инк. (Us)
Publication of RU2006112576A publication Critical patent/RU2006112576A/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
RU2006112576/04A 2003-10-16 2004-10-06 Получение производных 3-азабицикло [3.1.0] гексана RU2006112576A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51188903P 2003-10-16 2003-10-16
US60/511,889 2003-10-16

Publications (1)

Publication Number Publication Date
RU2006112576A true RU2006112576A (ru) 2006-08-27

Family

ID=34465290

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006112576/04A RU2006112576A (ru) 2003-10-16 2004-10-06 Получение производных 3-азабицикло [3.1.0] гексана

Country Status (17)

Country Link
US (1) US7129263B2 (https=)
EP (1) EP1675829A1 (https=)
JP (1) JP2007508367A (https=)
KR (1) KR20060096038A (https=)
CN (1) CN1867548A (https=)
AR (1) AR046592A1 (https=)
AU (1) AU2004281229A1 (https=)
BR (1) BRPI0415459A (https=)
CA (1) CA2540860A1 (https=)
CO (1) CO5680416A2 (https=)
IL (1) IL174596A0 (https=)
MX (1) MXPA06004278A (https=)
NO (1) NO20062152L (https=)
RU (1) RU2006112576A (https=)
TW (1) TW200524866A (https=)
WO (1) WO2005037790A1 (https=)
ZA (1) ZA200601964B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003296324A1 (en) 2002-12-10 2004-06-30 Wyeth Aryl, aryloxy, and alkyloxy substituted 1h-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
KR20060095865A (ko) * 2003-10-14 2006-09-04 화이자 프로덕츠 인크. 글리신 수송 억제제로서의 비시클릭 [3.1.0] 유도체
WO2008075162A2 (en) * 2006-12-15 2008-06-26 Pfizer Limited Selective mu opioid receptor antagonists for the treatment of female sexual dysfunction
JP2013542929A (ja) 2010-09-28 2013-11-28 パナセア バイオテック リミテッド 新規ビシクロ環化合物
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
US9663463B2 (en) * 2013-11-20 2017-05-30 Sanwa Kagaku Kenkyusho Co., Ltd. 3-azabicyclo[3.1.0]hexane derivative and use thereof for medical purpose
KR20180004734A (ko) * 2015-05-20 2018-01-12 가부시키가이샤산와카가쿠켄큐쇼 신규 3-아자비시클로[3.1.0]헥산 유도체의 염의 결정 및 그의 의약 용도
US12356988B2 (en) 2018-03-05 2025-07-15 Corteva Agriscience Llc Process and intermediates for the preparation of certain mesoionic pesticides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI244481B (en) * 1998-12-23 2005-12-01 Pfizer 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
EP1440059B1 (en) * 2001-10-22 2008-04-16 Pfizer Products Inc. 3-azabicyclo(3.1.0)hexane derivatives as opioid receptor antagonists

Also Published As

Publication number Publication date
TW200524866A (en) 2005-08-01
AR046592A1 (es) 2005-12-14
CN1867548A (zh) 2006-11-22
BRPI0415459A (pt) 2006-12-19
US7129263B2 (en) 2006-10-31
WO2005037790A1 (en) 2005-04-28
CO5680416A2 (es) 2006-09-29
AU2004281229A1 (en) 2005-04-28
EP1675829A1 (en) 2006-07-05
CA2540860A1 (en) 2005-04-28
KR20060096038A (ko) 2006-09-05
US20050113437A1 (en) 2005-05-26
NO20062152L (no) 2006-05-12
ZA200601964B (en) 2007-04-25
IL174596A0 (en) 2006-08-20
MXPA06004278A (es) 2006-06-28
JP2007508367A (ja) 2007-04-05

Similar Documents

Publication Publication Date Title
JP2012510502A5 (https=)
JP2005511545A5 (https=)
RU2006112576A (ru) Получение производных 3-азабицикло [3.1.0] гексана
EP2428519A3 (en) Process for the preparation of 17-vinyl- triflates as intermediates
JP2006501295A5 (https=)
JP2001519410A5 (https=)
JP2003503387A5 (https=)
KR930012016A (ko) 산불안정화합물의 경구용약제를 제조하는 방법
JP2004525888A5 (https=)
JP2004507521A5 (https=)
JP2004528385A5 (https=)
JP2009504639A5 (https=)
JP2010505861A5 (https=)
RU98117457A (ru) Соединения производных окса- и тиа-диазола, способ их получения, фармацевтическая композиция и способы лечения
RU2006130686A (ru) Новые пиперидины в качестве модуляторов хемокинов (ccr)
JP2008503573A5 (https=)
JP2015512381A5 (https=)
JP2004538278A5 (https=)
JP2007508367A5 (https=)
RU2006125447A (ru) Синтетический способ восстановительного алкилирования индолов в с-3-положении
JP2018515550A5 (https=)
JP2000007634A5 (https=)
JPH11193290A5 (https=)
JP2008540595A5 (https=)
JP2002173612A5 (https=)

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20070730